Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » The Scan » RNAi Drug for Acute Hepatic Porphyria

RNAi Drug for Acute Hepatic Porphyria

Nov 21, 2019

The US Food and Drug Administration has approved the RNA interference drug givosiran (Alnylam Pharmaceuticals' Givlaari) to treat acute hepatic porphyria in adults, according to the agency.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Call to Expand

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

Additional Suit

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Racism in Public Health

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

PNAS Studies Look at Inca Resettlement, Spermatogonial Stem Cell Transcriptomes, More

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Dante Labs Software Nabs CE Mark for Interpretation of Whole-Genome Sequencing Data

  2. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  3. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.